RAB DIAGNOSTICS AS
Developing predictive biomarkers for optimizing Antibody-Drug Conjugate therapies.
Yleiskatsaus
- Tuntematon
- Työntekijät
- 325t NOK
- Liikevaihto
- 2023
- Perustettu
Avainpäättäjät
Anette Weyergang
CEO
Anne Mathilde Kvamme
Board Member
Rosanne Welcher
Advisory board member
Ole Dahlberg
Board Member
+5 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Rab Diagnostics is a specialized biotechnology company headquartered in Oslo, Norway, focusing on biomarker development specifically for oncology-focused Antibody-Drug Conjugates (ADCs). They leverage their proprietary RabCANCER platform and deep expertise in intracellular drug trafficking to genera...